News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ESMO: New Therapy Boosts Survival in Triple Negative BrCA, Texas Oncology Reveals


10/11/2010 6:31:03 AM

MedPageToday -- MILAN -- An experimental targeted agent significantly extended survival among women with hard-to-treat "triple negative" metastatic breast cancer, researchers reported here.

Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES